PARP1 and neoplasm: In summary, the toxicity profile of [211At]PTT was driven by PARP1 expression in normal tissues and was predictable, however; we observed a differential sensitivity between normal and tumor tissue that likely afforded a therapeutic window for [211At]PTT treatment.